Clinical trial
Safety And Tolerability Study In Patients With Chronic Obstructive Pulmonary…
NCT00376714 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00376714 |
|---|---|
| Title | Safety And Tolerability Study In Patients With Chronic Obstructive Pulmonary Disease |
| Official title | A Randomised, Double-Blind, Placebo-Controlled, Dose Ascending, 3 Period Crossover Study To Examine The Safety, Tolerability, Pharmacodynamics And Pharmacokinetics Of Repeat Inhaled Doses Of GSK233705B In COPD Subjects. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive |
| Intervention type | Drug |
| Interventions | GSK233705 |
| Enrollment | 45 |
| Start date | Aug 16, 2006 |
| Completion | Apr 3, 2007 |
| First posted | Sep 15, 2006 |
| Last update posted | Jun 7, 2018 |
| Countries | Belgium, Sweden |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: